相关实验视频
Updated: Jul 2, 2025

08:48
Author Spotlight: Decoding Mitochondrial Aging
Published on: June 30, 2023
3.9K
在阿尔茨海默氏病中,CoQ10和线粒体功能障碍
1Department of Psychiatry, First Faculty of Medicine, Charles University and General University Hospital in Prague, Ke Karlovu 11, 120 00 Prague, Czech Republic.
Antioxidants (Basel, Switzerland)
|February 24, 2024
概括
辅酶Q10 (CoQ10) 可能通过改善线粒体功能和减少氧化应激来帮助治疗阿尔茨海默病 (AD). 这种抗氧化剂在恢复细胞能量和预防AD病理方面表现有前途.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 阿尔茨海默氏病 (AD) 的发病包括粉样β (Aβ) 和病理,线粒体功能障碍和氧化应激.
- 早期生物标志物和风险因素是了解AD进展的关键.
- 共酶Q10 (CoQ10) 对于线粒体电子运输和抗氧化剂防御至关重要.
研究的目的:
- 审查CoQ10在AD病理生理学中的作用.
- 评估CoQ10及其类似物作为AD的潜在药物治疗方法.
主要方法:
- 关于AD病变发生的文献综述.
- 分析CoQ10在线粒体功能和氧化应激中的作用.
- 在阿尔茨海默病模型和人类研究中对CoQ10进行现有研究的评估.
主要成果:
- CoQ10 缺乏与在AD中观察到的线粒体功能障碍有关.
- CoQ10的抗氧化和生物能量特性可以抵消与AD相关的细胞损伤.
- 用CoQ10进行药理干预可能会恢复线粒体功能并减轻Aβ和tau病理.
结论:
- 辅酶Q10对阿尔茨海默病具有显著的治疗潜力.
- 用CoQ10准线粒体功能障碍和氧化应激可能提供一种新的AD治疗策略.
- 需要进一步的临床研究来证实CoQ10在AD药物治疗中的疗效.
相关概念视频
Electron Transport Chain: Complex I and II
13.3K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
13.3K
Mitochondria
12.6K
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
12.6K
Alzheimer's Disease: Overview
484
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
484
The Electron Transport Chain
16.7K
The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
16.7K
Mitochondrial Membranes
10.3K
A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
10.3K
Alzheimer's Disease: Treatment
189
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
189

